Cue Biopharma, Inc.
CUE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $65,132 | $67,646 | $80,920 |
| - Cash | $11,701 | $27,492 | $13,136 | $22,459 |
| + Debt | $2,684 | $7,634 | $7,125 | $8,876 |
| Enterprise Value | – | $45,274 | $61,635 | $67,337 |
| Revenue | $2,149 | $2,954 | $421 | $1,576 |
| % Growth | -27.3% | 601.7% | -73.3% | – |
| Gross Profit | $2,070 | $2,954 | $421 | $1,576 |
| % Margin | 96.3% | 100% | 100% | 100% |
| EBITDA | -$7,294 | -$7,641 | -$11,247 | -$9,245 |
| % Margin | -339.4% | -258.7% | -2,671.5% | -586.6% |
| Net Income | -$7,448 | -$8,482 | -$12,257 | -$9,496 |
| % Margin | -346.6% | -287.1% | -2,911.4% | -602.5% |
| EPS Diluted | -0.07 | -0.089 | -0.17 | -0.13 |
| % Growth | 21.2% | 47.8% | -30.8% | – |
| Operating Cash Flow | -$9,024 | -$3,415 | -$8,172 | -$9,028 |
| Capital Expenditures | $0 | -$27 | -$150 | -$2 |
| Free Cash Flow | -$9,024 | -$3,442 | -$8,322 | -$9,030 |